Deconstructing "malaria": West Africa as the next front for dengue fever surveillance and control

Acta Tropica

Volumn 134, Issue 1, 2014, Pages 58-65

  Stoler, Justin ^a,b   al Dashti, Rawan ^b   Anto, Francis ^c   Fobil, Julius N ^c   Awandare, Gordon A ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

Author keywords

Africa; Dengue; Febrile illness; Ghana; Malaria

Indexed keywords

ARTEMISININ; ARTESUNATE; DENGUE VACCINE; MALARIA VACCINE;

DENGUE FEVER; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE VECTOR; MALARIA; PUBLIC HEALTH;

AFRICA; CLIMATE CHANGE; DENGUE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE SURVEILLANCE; DRUG EFFICACY; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MALARIA; NONHUMAN; PARASITE TRANSMISSION; POPULATION GROWTH; REVIEW; SEROPREVALENCE; URBANIZATION; COMMUNICABLE DISEASES, EMERGING; EPIDEMIOLOGICAL MONITORING; EPIDEMIOLOGY; PROCEDURES;

GHANA;

AFRICA, WESTERN; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DENGUE; EPIDEMIOLOGICAL MONITORING; HUMANS;

EID: 84896486428     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2014.02.017     Document Type: Review

References (146)

1. Aaby P., Bandim Health Project Dengue exists in Bissau 2011, INDEPTH.
2. Adekolu-John E.O., Fagbami A.H. Arthropod-borne virus antibodies in sera of residents of Kainji Lake Basin, Nigeria 1980. Trans. R. Soc. Trop. Med. Hyg. 1983, 77:149-151.
3. Akoua-Koffi C., Diarrassouba S., Benie V.B., Ngbichi J.M., Bozoua T., Bosson A., Akran V., Carnevale P., Ehouman A. Investigation surrounding a fatal case of yellow fever in Cote d'Ivoire in 1999. Bull. Soc. Pathol. Exot. 2001, 94:227-230.
4. Amarasinghe A., Kuritsk J.N., Letson G.W., Margolis H.S. Dengue virus infection in Africa. Emerg. Infect. Dis. 2011, 17:1349-1354.
5. Amexo M., Tolhurst R., Barnish G., Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004, 364:1896-1898.
6. Anders K.L., Hay S.I. Lessons from malaria control to help meet the rising challenge of dengue. Lancet Infect. Dis. 2012, 12:977-984.
7. Anthony M., Burrows J., Duparc S., JMoehrle J., Wells T. The global pipeline of new medicines for the control and elimination of malaria. Malar. J. 2012, 11:316.
8. Appawu M., Dadzie S., Abdul H., Asmah H., Boakye D., Wilson M., Ofori-Adjei D. Surveillance of viral haemorrhagic fevers in Ghana: entomological assessment of the risk of transmission in the northern regions. Ghana Med. J. 2006, 40:137-141.
9. Åström C., Rocklöv J., Hales S., Béguin A., Louis V., Sauerborn R. Potential distribution of dengue fever under scenarios of climate change and economic development. EcoHealth 2012, 9:448-454.
10. Baba M.M., Saron M.-F., Vance V.A., Adeniji J.A., Diop O., Olaleye D. Dengue virus infections in patients suspected of malaria/typhoid in Nigeria. J. Am. Sci. 2009, 5:129-134.
11. Bai Z.J., Liu L.C., Tu Z., Yao L.S., Liu J.W., Xu B., Tang B.H., Liu J.H., Wan Y.J., Fang M.Y., Chen W.J. Real-time PCR for detecting circulating dengue virus in the Guangdong Province of China in 2006. J. Med. Microbiol. 2008, 57:1547-1552.
12. Balmaseda A., Guzman M.G., Hammond S., Robleto G., Flores C., Tellez Y., Videa E., Saborio S., Perez L., Sandoval E., Rodriguez Y., Harris E. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin. Diagn. Lab. Immunol. 2003, 10:317-322.
13. Balmaseda A., Saborio S., Tellez Y., Mercado J.C., Pérez L., Hammond S.N., Rocha C., Kuan G., Harris E. Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J. Clin. Virol. 2008, 43:287-291.
14. Banu S., Hu W., Hurst C., Tong S. Dengue transmission in the Asia-Pacific region: impact of climate change and socio-environmental factors. Trop. Med. Int. Health 2011, 16:598-607.
15. Beatty M.E., Beutels P., Meltzer M.I., Shepard D.S., Hombach J., Hutubessy R., Dessis D., Coudeville L., Dervaux B., Wichmann O., Margolis H.S., Kuritsky J.N. Health economics of dengue: a systematic literature review and expert panel's assessment. Am. J. Trop. Med. Hyg. 2011, 84:473-488.
16. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., Drake J.M., Brownstein J.S., Hoen A.G., Sankoh O., Myers M.F., George D.B., Jaenisch T., Wint G.R.W., Simmons C.P., Scott T.W., Farrar J.J., Hay S.I. The global distribution and burden of dengue. Nature 2013, 496:504-507.
17. Biritwum R.B., Welbeck J., Barnish G. Incidence and management of malaria in two communities of different socio-economic level, in Accra, Ghana. Ann. Trop. Med. Parasitol. 2000, 94:771-778.
18. Bisoffi Z., Buonfrate D. When fever is not malaria. Lancet Global Health 2013, 1:e11-e12.
19. Brady O.J., Gething P.W., Bhatt S., Messina J.P., Brownstein J.S., Hoen A.G., Moyes C.L., Farlow A.W., Scott T.W., Hay S.I. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl. Trop. Dis. 2012, 6:e1760.
20. Butenko A.M. Arbovirus circulation in the Republic of Guinea. Med. Parazitol. (Mosk.) 1996, (April-June):40-45.
21. Bygbjerg I.C. Double burden of noncommunicable and infectious diseases in developing countries. Science 2012, 337:1499-1501.
22. Carey D.E., Causey O.R., Reddy S., Cooke A.R. Dengue viruses from febrile patients in Nigeria, 1964-68. Lancet 1971, 297:105-106.
23. Centers for Disease Control and Prevention (CDC) Aedes albopictus introduction into continental Africa, 1991. MMWR Morb. Mortal. Wkly. Rep. 1991, 40:836-838.
24. Chandler C., Jones C., Boniface G., Juma K., Reyburn H., Whitty C. Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar. J. 2008, 7:53.
25. Chandler C., Mwangi R., Mbakilwa H., Olomi R., Whitty C.J.M., Reyburn H. Malaria overdiagnosis: is patient pressure the problem?. Health Policy Plan. 2008, 23:170-178.
26. Chandramohan D., Jaffar S., Greenwood B. Use of clinical algorithms for diagnosing malaria. Trop. Med. Int. Health 2002, 7:45-52.
27. Chinery W.A. A survey of mosquito breeding in Accra, Ghana during a 2 year period of larval mosquito control. Part 3: the breeding of Aedes (Stegomyia) aegypti, Linnaeus, in Accra. Ghana Med. J. 1970, 9:197-200.
28. Chinery W.A. Effects of ecological changes on the malaria vectors Anopheles funestus and the Anopheles gambiae complex of mosquitoes in Accra. Ghana. J. Trop. Med. Hyg. 1984, 87:75-81.
29. Chinery W.A. A change in the breeding pattern of Aedes aegypti (Linnaeus) in domestic water receptacles during rapid urbanization period. Ghana J. Sci. 1991, 31(1). http://www.ajol.info/index.php/gjs/article/view/15829.
30. Chinery W.A. Impact of rapid urbanization on mosquitoes and their disease transmission potential in Accra and Tema. Ghana. Afr. J. Med. Med. Sci. 1995, 24:179-188.
31. Chinery W.A. Impact of rapid urbanization in Accra on the breeding patterns of two major mosquito species in traditional domestic water receptacles. Ghana J. Sci. 1999, 39:111-115.
32. Chiyaka C., Tatem A.J., Cohen J.M., Gething P.W., Johnston G., Gosling R., Laxminarayan R., Hay S.I., Smith D.L. The stability of malaria elimination. Science 2013, 339:909-910.
33. Colbourne M.J., Edington G.M. Mortality from malaria in Accra. J. Trop. Med. Hyg. 1954, 57:203-210.
34. Collenberg E., Ouedraogo T., Ganamé J., Fickenscher H., Kynast-Wolf G., Becher H., Kouyaté B., Kräusslich H.-G., Sangaré L., Tebit D.M. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J. Med. Virol. 2006, 78:683-692.
35. Colón-González F.J., Fezzi C., Lake I.R., Hunter P.R. The effects of weather and climate change on dengue. PLoS Negl. Trop. Dis. 2013, 7:e2503.
36. Cordellier R., Bouchite B., Roche J.C., Monteny N., Diaco B., Akoliba P. Circulation selvatique du virus Dengue 2 en 1980 dans les savanes sub-soudaniennes de CÔte d'Ivoire. Cahiers - ORSTOM. Entomol. Méd. Parasitol. 1983, 21:165-179.
37. Crump J.A., Morrissey A.B., Nicholson W.L., Massung R.F., Stoddard R.A., Galloway R.L., Ooi E.E., Maro V.P., Saganda W., Kinabo G.D., Muiruri C., Bartlett J.A. Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Negl. Trop. Dis. 2013, 7:e2324.
38. Davis M. Planet of Slums 2006, Verso, New York.
39. Dayan G.H., Garbes P., Noriega F., Izoton de Sadovsky A.D., Rodrigues P.M., Giuberti C., Dietze R. Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil. Am. J. Trop. Med. Hyg. 2013, 89:1058-1065.
40. de Laval F., Plumet S., Simon F., Deparis X., Leparc-Goffart I. Dengue surveillance among French military in Africa. Emerg. Infect. Dis. 2012, 18:342-343.
41. Diallo M., Ba Y., Sall A.A., Diop O.M., Ndione J.A., Mondo M., Girault L., Mathiot C. Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999-2000: entomologic findings and epidemiologic considerations. Emerg. Infect. Dis. 2003, 9:362-367.
42. Diallo M., Nabeth P., Ba K., Sall A.A., Ba Y., Mondo M., Girault L., Abdalahi M.O., Mathiot C. Mosquito vectors of the 1998-1999 outbreak of Rift Valley fever and other arboviruses (Bagaza, Sanar Wesselsbron and West Nile) in Mauritania and Senegal. Med. Vet. Entomol. 2005, 19:119-126.
43. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., Lwin K.M., Ariey F., Hanpithakpong W., Lee S.J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S.S., Yeung S., Singhasivanon P., Day N.P.J., Lindegardh N., Socheat D., White N.J. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
44. Dondorp A.M., Yeung S., White L., Nguon C., Day N.P.J., Socheat D., von Seidlein L. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 2010, 8:272-280.
45. Donovan C., Siadat B., Frimpong J. Seasonal and socioeconomic variations in clinical and self-reported malaria in Accra, Ghana: evidence from facility data and a community survey. Ghana Med. J. 2012, 46:85-94.
46. Durand J.P., Vallee L., de Pina J.J., Tolou H. Isolation of a dengue type 1 virus from a soldier in West Africa (Cote d'Ivoire). Emerg. Infect. Dis. 2000, 6:83-84.
47. Durbin A.P., Kirkpatrick B.D., Pierce K.K., Elwood D., Larsson C.J., Lindow J.C., Tibery C., Sabundayo B.P., Shaffer D., Talaat K.R., Hynes N.A., Wanionek K., Carmolli M.P., Luke C.J., Murphy B.R., Subbarao K., Whitehead S.S. A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial. J. Infect. Dis. 2013, 207:957-965.
48. Ebke J., Schäfer E. Detection of hemagglutination-inhibiting antibodies to arboviruses in sera of young individuals in the Federal Republic of Germany and in the Republic of Togo (West Africa). Zentralbl Bakteriol Orig A 1971, 218:149-159.
49. Eisenhut M. Diagnosis of viral hemorrhagic fevers in travelers returning from West Africa. J. Travel Med. 2013, 20:63.
50. Eisenhut M., Schwarz T.F., Hegenscheid B. Seroprevalence of dengue, chikungunya and sindbis virus infections in German aid workers. Infection 1999, 27:82-85.
51. Fagbami A.H., Monath T.P., Fabiyi A. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans. R. Soc. Trop. Med. Hyg. 1977, 71:60-65.
52. Fobil J.N., Levers C., Lakes T., Loag W., Kraemer A., May J. Mapping urban malaria and diarrhea mortality in Accra, Ghana: evidence of vulnerabilities and implications for urban health policy. J. Urban Health 2012, 89:977-991.
53. Font F., Alonso Gonzalez M., Nathan R., Kimario J., Lwilla F., Ascaso C., Tanner M., Menendez C., Alonso P. Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania. Trop. Med. Int. Health 2001, 6:423-428.
54. Franco L., Di Caro A., Carletti F., Vapalahti O., Renaudat C., Zeller H., Tenorio A. Recent expansion of dengue virus serotype 3 in West Africa. Euro Surveill. 2010, 15:19490.
55. Franco L., Palacios G., Martinez J.A., Vazquez A., Savji N., De Ory F., Sanchez-Seco M.P., Martin D., Lipkin W.I., Tenorio A. First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa. PLoS Negl. Trop. Dis. 2011, 5:e1251.
56. Free C., Phillips G., Felix L., Galli L., Patel V., Edwards P. The effectiveness of M-health technologies for improving health and health services: a systematic review protocol. BMC Res. Notes 2010, 3:250.
57. GIDEON Global Infectious Diseases and Epidemiology Online Network (GIDEON) database 2011.
58. Greenwood B.M., Targett G.A. Malaria vaccines and the new malaria agenda. Clin. Microbiol. Infect. 2011, 17:1600-1607.
59. Gubler D.J. The global emergence/resurgence of arboviral diseases as public health problems. Arch. Med. Res. 2002, 33:330-342.
60. Gubler D.J. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?. Comp. Immunol. Microbiol. Infect. Dis. 2004, 27:319-330.
61. Gubler D.J. Dengue, urbanization and globalization: the unholy trinity of the 21(st) century. Trop. Med. Health 2011, 39:3-11.
62. Guy B., Barrere B., Malinowski C., Saville M., Teyssou R., Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi pasteur tetravalent dengue vaccine. Vaccine 2011, 29:7229-7241.
63. Hales S., de Wet N., Maindonald J., Woodward A. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 2002, 360:830-834.
64. Halstead S.B., Streit T.G., Lafontant J.G., Putvatana R., Russell K., Sun W., Kanesa-Thasan N., Hayes C.G., Watts D.M. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am. J. Trop. Med. Hyg. 2001, 65:180-183.
65. Hay S.I., George D.B., Moyes C.L., Brownstein J.S. Big data opportunities for global infectious disease surveillance. PLoS Med. 2013, 10:e1001413.
66. Hertz J.T., Munishi O.M., Sharp J.P., Reddy E.A., Crump J.A. Comparing actual and perceived causes of fever among community members in a low malaria transmission setting in northern Tanzania. Trop. Med. Int. Health 2013, 18:1406-1415.
67. Hervy J.-P., Legros F., Roche J.C., Monteny N., Diaco B. Circulation du virus dengue 2 dans plusieurs milieux boisés des savanes soudaniennes de la région de Bobo-Dioulasso (Burkina Faso). Med. Parasitol. 1985, 22:135-143.
68. Huhtamo E., Uzcategui N.Y., Siikamaki H., Saarinen A., Piiparinen H., Vaheri A., Vapalahti O. Molecular epidemiology of dengue virus strains from Finnish travelers. Emerg. Infect. Dis. 2008, 14:80-83.
69. Hume J., Barnish G., Mangal T., Armazio L., Streat E., Bates I. Household cost of malaria overdiagnosis in rural Mozambique. Malar. J. 2008, 7:33.
70. Hunsperger E.A., Yoksan S., Buchy P., Nguyen V.C., Sekaran S.D., Enria D.A., Pelegrino J.L., Vazquez S., Artsob H., Drebot M., Gubler D.J., Halstead S.B., Guzman M.G., Margolis H.S., Nathanson C.M., Rizzo Lic N.R., Bessoff K.E., Kliks S., Peeling R.W. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg. Infect. Dis. 2009, 15:436-440.
71. Innis B.L., Nisalak A., Nimmannitya S., Kusalerdchariya S., Chongswasdi V., Suntayakorn S., Puttisri P., Hoke C.H. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 1989, 40:418-427.
72. Jentes E.S., Robinson J., Johnson B.W., Conde I., Sakouvougui Y., Iverson J., Beecher S., Bah M.A., Diakite F., Coulibaly M., Bausch D.G. Acute arboviral infections in Guinea, West Africa, 2006. Am. J. Trop. Med. Hyg. 2010, 83:388-394.
73. Jombo G.T.A., Araoye M.A., Damen J.G. Malaria self medications and choices of drugs for its treatment among residents of a malaria endemic community in West Africa. Asian Pac. J. Trop. Dis. 2011, 1:10-16.
74. JSI Research and Training Institute Report of the Ghana Urban Malaria Study 2013, JSI Research and Training Institute, Inc., Accra, Ghana.
75. Klinkenberg E., McCall P., Wilson M., Amerasinghe F., Donnelly M. Impact of urban agriculture on malaria vectors in Accra, Ghana. Malar. J. 2008, 7:151.
76. Kokwaro G. Ongoing challenges in the management of malaria. Malar. J. 2009, 8:S2.
77. Koram K.A., Molyneux M.E. When is "malaria" malaria? The different burdens of malaria infection, malaria disease, and malaria-like illnesses. Am. J. Trop. Med. Hyg. 2007, 77:1-5.
78. Kyle J.L., Harris E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 2008, 62:71-92.
79. Lieu T.A., Thompson K.M., Prosser L.A., O'Brien M.A., Yusuf H.R., Shefer A.M., Weinstein M.C., Rickert D.L. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev. Vaccines 2002, 1:433-442.
80. Lwin M.O., Vijaykumar S., Fernando O.N.N., Cheong S.A., Rathnayake V.S., Lim G., Theng Y.-L., Chaudhuri S., Foo S. A 21st century approach to tackling dengue: crowdsourced surveillance, predictive mapping and tailored communication. Acta Trop. 2014, 130:100-107.
81. Malisa A., Pearce R., Abdulla S., Mshinda H., Kachur P., Bloland P., Roper C. Drug coverage in treatment of malaria and the consequences for resistance evolution - evidence from the use of sulphadoxine/pyrimethamine. Malar. J. 2010, 9:190.
82. Malm K., Bart-Plange C., Armah G., Gyapong J., Owusu-Adjei S., Koram K., Binka F. Malaria as a cause of acute febrile illness in an urban paediatric population in Ghana. Annual Meeting of the American Society of Tropical Medicine and Hygiene 2012.
83. Mariner J.C., Morrill J., Ksiazek T.G. Antibodies to hemorrhagic fever viruses in domestic livestock in Niger: Rift Valley fever and Crimean-Congo hemorrhagic fever. Am. J. Trop. Med. Hyg. 1995, 53:217-221.
84. Marquez P.V., Farrington J.L. The challenge of non-communicable diseases and road traffic injuries in sub-Saharan Africa 2013, The World Bank, Washington DC.
85. McArthur M.A., Sztein M.B., Edelman R. Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert Rev. Vaccines 2013, 12:933-953.
86. Moi M.L., Takasaki T., Kotaki A., Tajima S., Lim C.K., Sakamoto M., Iwagoe H., Kobayashi K., Kurane I. Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire. Emerg. Infect. Dis. 2010, 16:1770-1772.
87. Moi M.L., Ujiie M., Takasaki T., Kurane I. Dengue virus infection in travellers returning from Benin to France, July-August, 2010. Euro Surveill. 2010, 15:19674.
88. Monath T.P. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2395-2400.
89. Monath T.P., Craven R.B., Adjukiewicz A., Germain M., Francy D.B., Ferrara L., Samba E.M., N'Jie H., Cham K., Fitzgerald S.A., Crippen P.H., Simpson D.I., Bowen E.T., Fabiyi A., Salaun J.J. Yellow fever in the Gambia, 1978-1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am. J. Trop. Med. Hyg. 1980, 29:912-928.
90. Morin C.W., Comrie A.C., Ernst K. Climate and dengue transmission: evidence and implications. Environ. Health Perspect. 2013, 121:1264-1272.
91. Mosha J.F., Conteh L., Tediosi F., Gesase S., Bruce J., Chandramohan D., Gosling R. Cost implications of improving malaria diagnosis: findings from North-Eastern Tanzania. PLoS ONE 2010, 5:e8707.
92. N'Guessan R., Corbel V., Akogbeto M., Rowland M. Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area. Benin. Emerg. Infect. Dis. 2007, 13:199-206.
93. Nankabirwa J., Zurovac D., Njogu J., Rwakimari J., Counihan H., Snow R., Tibenderana J. Malaria misdiagnosis in Uganda - implications for policy change. Malar. J. 2009, 8:66.
94. Ninove L., Parola P., Baronti C., De Lamballerie X., Gautret P., Doudier B., Charrel R.N. Dengue virus type 3 infection in traveler returning from West Africa. Emerg. Infect. Dis. 2009, 15:1871-1872.
95. Nkoghe D., Kassa R.F.K., Bisvigou U., Caron M., Grard G., Leroy E.M. No clinical or biological difference between chikungunya and dengue fever during the 2010 Gabonese outbreak. Infect. Dis. Rep. 2012, 4:11-13.
96. Nonvignon J., Chinbuah M.A., Gyapong M., Abbey M., Awini E., Gyapong J.O., Aikins M. Is home management of fevers a cost-effective way of reducing under-five mortality in Africa? The case of a rural Ghanaian district. Trop. Med. Int. Health 2012, 17:951-957.
97. O'Dempsey T.J.D., McArdle T.F., Laurence B.E., Lamont A.C., Todd J.E., Greenwood B.M. Overlap in the clinical features of pneumonia and malaria in African children. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:662-665.
98. Oladosu O.O., Oyibo W.A. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos, Nigeria. ISRN Infect. Dis. 2013, 2013:6.
99. Olotu A., Fegan G., Wambua J., Nyangweso G., Awuondo K.O., Leach A., Lievens M., Leboulleux D., Njuguna P., Peshu N., Marsh K., Bejon P. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 2013, 368:1111-1120.
100. Opoku A.A., Ansa-Asare O.D., Amoako J. The occurrences and habitat characteristics of mosquitoes in Accra, Ghana. W. Afr. J. Appl. Ecol. 2007, 11:81-86.
101. Palsson K., Jaenson T.G., Dias F., Laugen A.T., Bjorkman A. Endophilic Anopheles mosquitoes in Guinea Bissau, west Africa, in relation to human housing conditions. J. Med. Entomol. 2004, 41:746-752.
102. Patterson K.D. Health in urban Ghana: the case of Accra 1900-1940 [1]. Soc. Sci. Med. [B] 1979, 13:251-268.
103. Peeling R.W., Artsob H., Pelegrino J.L., Buchy P., Cardosa M.J., Devi S., Enria D.A., Farrar J., Gubler D.J., Guzman M.G., Halstead S.B., Hunsperger E., Kliks S., Margolis H.S., Nathanson C.M., Nguyen V.C., Rizzo N., Vazquez S., Yoksan S. Evaluation of diagnostic tests: dengue. Nat. Rev. Microbiol. 2010, 8:S30-S37.
104. Phoutrides E.K., Coulibaly M.B., George C.M., Sacko A., Traore S., Bessoff K., Wiley M.R., Kolivras K.N., Adelman Z., Traore M., Hunsperger E.A. Dengue virus seroprevalence among febrile patients in Bamako, Mali: results of a 2006 surveillance study. Vector Borne Zoonotic Dis. 2011, 11:1479-1485.
105. Pichon G., Hamon J., Mouchet J. Groupes ethniques et foyers potentiels de fièvre jaune dans les états francophones d'Afrique occidentale;considérations sur les méthodes de lutte contre Aedes aegypti. Cahiers - ORSTOM. Entomol. Méd. Parasitol. 1969, 7:39-50.
106. Pindolia D.K., Garcia A.J., Wesolowski A., Smith D.L., Buckee C.O., Noor A.M., Snow R.W., Tatem A.J. Human movement data for malaria control and elimination strategic planning. Malar. J. 2012, 11:205.
107. Pond R.S. Malaria indicator surveys demonstrate a markedly lower prevalence of malaria in large cities of sub-Saharan Africa. Malar. J. 2013, 12:313.
108. Posey D.L., O'Rourke T., Roehrig J.T., Lanciotti R.S., Weinberg M., Maloney S. O'Nyong-nyong fever in West Africa. Am. J. Trop. Med. Hyg. 2005, 73:32.
109. Powers A.M., Logue C.H. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 2007, 88:2363-2377.
110. ProMED-mail, 2009. Dengue/DHF Update 2009 (40), Promed. International Society for Infectious Diseases.
111. Ratmanov P., Mediannikov O., Raoult D. Vectorborne diseases in West Africa: geographic distribution and geospatial characteristics. Trans. R. Soc. Trop. Med. Hyg. 2013, 107:273-284.
112. Reyburn H., Mbakilwa H., Mwangi R., Mwerinde O., Olomi R., Drakeley C., Whitty C. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 2007, 334:403.
113. Reyburn H., Mbatia R., Drakeley C., Carneiro I., Mwakasungula E., Mwerinde O., Saganda K., Shao J., Kitua A., Olomi R., Greenwood B.M., Whitty C.J.M. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004, 329:1212.
114. Robert V., Lhuillier M., Meunier D., Sarthou J.L., Monteny N., Digoutte J.P., Cornet M., Germain M., Cordellier R. Yellow fever virus, dengue 2 and other arboviruses isolated from mosquitos, in Burkina Faso, from 1983 to 1986. Entomological and epidemiological considerations. Bull. Soc. Pathol. Exot. 1993, 86:90-100.
115. Rogers D.J., Suk J.E., Semenza J.C. Using global maps to predict the risk of dengue in Europe. Acta Trop. 2014, 129:1-14.
116. Sabchareon A., Wallace D., Sirivichayakul C., Limkittikul K., Chanthavanich P., Suvannadabba S., Jiwariyavej V., Dulyachai W., Pengsaa K., Wartel T.A., Moureau A., Saville M., Bouckenooghe A., Viviani S., Tornieporth N.G., Lang J. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012, 380:1559-1567.
117. Saluzzo J.F., Cornet M., Adam C., Eyraud M., Digoutte J.P. Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974-85. Bull. Soc. Pathol. Exot. Filiales 1986, 79:313-322.
118. Seder R.A., Chang L.-J., Enama M.E., Zephir K.L., Sarwar U.N., Gordon I.J., Holman L.A., James E.R., Billingsley P.F., Gunasekera A., Richman A., Chakravarty S., Manoj A., Velmurugan S., Li M., Ruben A.J., Li T., Eappen A.G., Stafford R.E., Plummer S.H., Hendel C.S., Novik L., Costner P.J.M., Mendoza F.H., Saunders J.G., Nason M.C., Richardson J.H., Murphy J., Davidson S.A., Richie T.L., Sedegah M., Sutamihardja A., Fahle G.A., Lyke K.E., Laurens M.B., Roederer M., Tewari K., Epstein J.E., Sim B.K.L., Ledgerwood J.E., Graham B.S., Hoffman S.L. The VRC 312 Study team, protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013, 341:1359-1365.
119. Sierra B.d.l.C., Kourí G., Guzmán M.G. Race: a risk factor for dengue hemorrhagic fever. Arch. Virol. 2007, 152:533-542.
120. Smit P.W., Elliott I., Peeling R.W., Mabey D., Newton P.N. An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am. J. Trop. Med. Hyg. 2014, 90:195-210.
121. Stahl H.C., Butenschoen V.M., Tran H.T., Gozzer E., Skewes R., Mahendradhata Y., Runge-Ranzinger S., Kroeger A., Farlow A. Cost of dengue outbreaks: literature review and country case studies. BMC Public Health 2013, 13:1048.
122. Stephenson I., Roper J., Fraser M., Nicholson K., Wiselka M. Dengue fever in febrile returning travellers to a UK regional infectious diseases unit. Travel Med. Infect. Dis. 2003, 1:89-93.
123. Surtees G. The distribution, density and seasonal prevalence of Aedes aegypti in West Africa. Bull. World Health Organ. 1967, 36:539-540.
124. Tanner M., de Savigny D. Malaria eradication back on the table. Bull. World Health Organ. 2008, 86:82.
125. Tatem A.J., Gething P.W., Smith D.L., Hay S.I. Urbanization and the global malaria recession. Malar. J. 2013, 12:133.
126. Tatem A.J., Guerra C.A., Kabaria C.W., Noor A.M., Hay S.I. Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity. Malar. J. 2008, 7:218.
127. Thai K.T., Anders K.L. The role of climate variability and change in the transmission dynamics and geographic distribution of dengue. Exp. Biol. Med. (Maywood, N.J.) 2011, 236:944-954.
128. Thomas S.J., Eckels K.H., Carletti I., De La Barrera R., Dessy F., Fernandez S., Putnak R., Toussaint J.-F., Sun W., Bauer K., Gibbons R.V., Innis B.L. A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults. Am. J. Trop. Med. Hyg. 2013, 88:73-88.
129. Tomori O., Fabiyi A. Antibodies against arboviruses in Sierra Leone. Trop. Geogr. Med. 1976, 28:239-243.
130. Ujiie M., Moi M.L., Kobayashi T., Takeshita N., Kato Y., Takasaki T., Kanagawa S. Dengue virus type-3 infection in a traveler returning from Benin to Japan. J. Travel Med. 2012, 19:255-257.
131. United Nations World Urbanization Prospects: The 2010 Revision 2011, United Nations Population Division, Department of Economic and Social Affairs, New York, NY.
132. Van der Waals F.W., Asher D.M., Goudsmit J., Pomeroy K.L., Karabatsos N., Gajdusek D.C. Post-encephalitic epilepsy and arbovirus infections in an isolated rainforest area of central Liberia. Trop. Geogr. Med. 1986, 38:203-208.
133. Van Dillen J., De Jager A., De Jong I., Wendte J. Overdiagnosis of malaria in hospitalized patients in Namibia. Trop. Doct. 2007, 37:185-186.
134. Vasilakis N., Holmes E.C., Fokam E.B., Faye O., Diallo M., Sall A.A., Weaver S.C. Evolutionary processes among sylvatic dengue type 2 viruses. J. Virol. 2007, 81:9591-9595.
135. Veronique, A.A., 2012. IDAMS/INDEPTH questionnaire response.
136. Villar L.Á., Rivera-Medina D.M., Arredondo-García J.L., Boaz M., Starr-Spires L., Thakur M., Zambrano B., Miranda M.C., Rivas E., Dayan G.H. Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. Pediatr. Infect. Dis. J. 2013, 32:1102-1109. 1110.1097/INF.1100b1013e31829b38022.
137. Wan S.-W., Lin C.-F., Wang S., Chen Y.-H., Yeh T.-M., Liu H.-S., Anderson R., Lin Y.-S. Current progress in dengue vaccines. J. Biomed. Sci. 2013, 20:37.
138. Wichmann O., Mühlberger N., Jelinek T. Dengue - the underestimated risk in travellers. Dengue Bull. 2003, 27:126-137.
139. Wongsrichanalai C., Barcus M.J., Muth S., Sutamihardja A., Wernsdorfer W.H. A review of malaria diagnostic tools: Microscopy and rapid diagnostic test (RDT). Am. J. Trop. Med. Hyg. 2007, 77:119-127.
140. Woodruff A.W., Bowen E.T.W., Platt G.S. Viral-infections in travelers from tropical Africa. BMJ 1978, 1:956-958.
141. World Health Organization Report of the Consultation on: Key Issues in dengue vector control towards the operationalization of a global strategy 1995, WHO, Geneva.
142. World Health Organization Dengue in Africa: emergence of DENV-3, Cote d'Ivoire, 2008. Wkly. Epidemiol. Rec. 2009, 84:85-88.
143. World Health Organization World Malaria Report 2012, WHO, Geneva.
144. Ye Y., Madise N., Ndugwa R., Ochola S., Snow R.W. Fever treatment in the absence of malaria transmission in an urban informal settlement in Nairobi, Kenya. Malar. J. 2009, 8:160.
145. Yeboah-Antwi K., Pilingana P., Macleod W.B., Semrau K., Siazeele K., Kalesha P., Hamainza B., Seidenberg P., Mazimba A., Sabin L., Kamholz K., Thea D.M., Hamer D.H. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. PLoS Med. 2010, 7:e1000340.
146. Zeller H., Traore-Lamizana M., Monlun E., Hervy J.P., Mondo M., Diqoutte J.P. Dengue-2 virus isolation from humans during an epizootic in southeastern Senegal in November, 1990. Res. Virol. 1992, 143:101-102.